Viridian Therapeutics
VRDN
$13.45
Share price
-8.07%
Change (1 day)
-41.29%
Change (1 year)
Categories
Viridian Therapeutics (VRDN) - Total liabilities
Total liabilities on the balance sheet as of December 2023 : $48.4 M
According to Viridian Therapeutics's latest financial reports the company's total liabilities are $48.4 M. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Viridian Therapeutics - Total liabilities on balance sheet (from 2013 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023-12-31 | $48.4 M | 20.92% |
| 2022-12-31 | $40.02 M | 150.28% |
| 2021-12-31 | $15.99 M | 42.57% |
| 2020-12-31 | $11.21 M | -22.68% |
| 2019-12-31 | $14.5 M | -1.99% |
| 2018-12-31 | $14.8 M | 5.96% |
| 2017-12-31 | $13.97 M | 204.71% |
| 2016-12-31 | $4.58 M | 83.99% |
| 2015-12-31 | $2.49 M | 18.78% |
| 2014-12-31 | $2.09 M | -92.39% |
| 2013-12-31 | $27.56 M | 13.78% |
| 2012-12-31 | $24.22 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $27.91 M | -42.32% | 🇺🇸 USA |